Eshwaran received his Masterís degree in Chemical Engineering from Arizona State University, USA in 2015. His Masterís research focused on colorimetric plasmonic nanosensors for the detection of therapeutic levels of ionizing radiation. He has several publications in highly reputed peer-reviewed journals such as ACS Nano, Wiley ChemNanoMat and ACS Applied Materials & Interfaces. He is also a reviewer for many journals including Cogent Medicine, International journal of Pharmaceutics, ACS Biomaterials Science & Engineering and Journal of Applied Pharmacy. Additionally, he is a member of the AIChE and IChemE, UK. At present, Eshwaran works at Insys Development Company, Inc., a specialty pharmaceutical company with a focus on providing therapeutic solutions to improve the lives of patients. Eshwaranís current research at Insys Development Company, Inc. is focused on the development of sublingual/nasal sprays and oral solutions.
Dr. Eshwaran's Research interests are Formulation Development, Design and development of Novel Drug Delivery Systems, Nanotechnology, Nanomedicine, and Synergistic Cancer Treatments.